New injection Y-3 put to the test: will it interfere with common medications?

This completed Phase 1 trial in 24 healthy Chinese adults aimed to see if a new drug called Y-3 (given as an injection) changes how the body processes three common medications: repaglinide (for diabetes), warfarin (a blood thinner), and omeprazole (for heartburn). Participants took these medications with and without Y-3, and researchers measured drug levels in the blood to check for interactions. The goal was to gather safety and dosing information for future use of Y-3.